摘要
mTOR(mammalian target of rapamycin,mTOR)是雷帕霉素在哺乳动物细胞内作用的蛋白激酶,通过PI3K/Akt信号磷酸化激活而调控细胞分裂、促进转录、信号翻译等。研究表明,mTOR在肿瘤的形成和发展中扮演着非常重要的角色,并参与肿瘤的侵袭和转移。目前,以mTOR为治疗靶点成为肿瘤治疗的研究新热点。本文就近年来有关mTOR靶标及其结合蛋白研究进展作一综述。
The mammalian target of rapamycin(mTOR)has been shown to link growth factor signaling and post-transcriptional control of protein translation through activation of the PI3K/Akt pathway,which is frequently involved in cell cycle progression.mTOR plays a very important role in the formation and development of the tumor and participates tumor invasion and metastasis.Therefore,mTOR-targeted therapy has shown promising role in the management of various cancers.This article reviewed the current status of researches on mTOR and its binding proteins in antitumor therapy.
出处
《现代肿瘤医学》
CAS
2012年第11期2435-2438,共4页
Journal of Modern Oncology
基金
福建省自然科学基金(编号:2008J0103)